tiprankstipranks
Advertisement
Advertisement
Jiangsu Recbio Wins HKEX Approval for Full Circulation of 141.9 Million H Shares
PremiumCompany AnnouncementsJiangsu Recbio Wins HKEX Approval for Full Circulation of 141.9 Million H Shares
3M ago
Recbio Gains CSRC Green Light for Full Circulation of 142 Million Domestic Shares as H Shares
Premium
Company Announcements
Recbio Gains CSRC Green Light for Full Circulation of 142 Million Domestic Shares as H Shares
4M ago
Recbio’s Shingles Vaccine NDA Accepted by China Regulator
Premium
Company Announcements
Recbio’s Shingles Vaccine NDA Accepted by China Regulator
5M ago
Jiangsu Recbio Technology Completes Issuance of Domestic Shares, Reshaping Shareholding Structure
PremiumCompany AnnouncementsJiangsu Recbio Technology Completes Issuance of Domestic Shares, Reshaping Shareholding Structure
5M ago
Jiangsu Recbio Technology Announces Key Governance Changes
Premium
Company Announcements
Jiangsu Recbio Technology Announces Key Governance Changes
6M ago
Jiangsu Recbio Announces Board Composition and Roles
Premium
Company Announcements
Jiangsu Recbio Announces Board Composition and Roles
6M ago
Jiangsu Recbio Completes Capital Alteration and Updates Business License
PremiumCompany AnnouncementsJiangsu Recbio Completes Capital Alteration and Updates Business License
6M ago
Jiangsu Recbio Expands Drug Production License for Shingles Vaccine
Premium
Company Announcements
Jiangsu Recbio Expands Drug Production License for Shingles Vaccine
6M ago
Jiangsu Recbio Completes Capital Verification for Domestic Shares Issuance
Premium
Company Announcements
Jiangsu Recbio Completes Capital Verification for Domestic Shares Issuance
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100